Covered recipient · General Payments record
VICTORIA TALLEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$164.93
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $164.93 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $48.52 | 3 |
| ABBVIE INC. | $24.18 | 1 |
| GlaxoSmithKline, LLC. | $18.03 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.71 | 1 |
| DEXCOM, INC. | $15.29 | 1 |
| PFIZER INC. | $14.83 | 1 |
| Exact Sciences Corporation | $14.58 | 1 |
| Merck Sharp & Dohme Corporation | $13.79 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $164.93 | 10 |
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.18 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106197166 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.71 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086240206 | CMS |
| Dexcom, Inc. | $15.29 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153342747 | CMS |
| Exact Sciences Corporation | $14.58 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114927436 | CMS |
| GlaxoSmithKline, LLC. | $18.03 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116281987 | CMS |
| Merck Sharp & Dohme LLC | $13.79 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141673525 | CMS |
| Novo Nordisk Inc | $17.00 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097316449 | CMS |
| Novo Nordisk Inc | $15.52 | 11/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097593766 | CMS |
| Novo Nordisk Inc | $16.00 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097269921 | CMS |
| PFIZER INC. | $14.83 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131535018 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.